India’s Point-of-Care (POC) Analyzers market is expected to be the fastest-growing Analyzers market in the Asia-Pacific region, followed by South Korea and China, and is estimated to be worth $70 million by 2030, according to GlobalData. The leading data and analytics company found that this growth will be driven by the increasing adoption of molecular diagnostics, an aging population, and a growing disease burden.

POC testing, also known as bedside testing, near-patient testing, remote testing, and mobile testing, is performed outside of a laboratory setting to facilitate rapid diagnosis at a low cost compared to conventional diagnostic tests, resulting in timely treatment, especially in resource-limited rural areas.

Shachee Singh, Medical Devices Analyst at GlobalData, comments: “Owing to the highly-dense rural population and lack of sufficient high-end, automated, and expensive diagnostic instruments in India, there is a need for affordable, accessible, and efficient testing. The increased availability of POC diagnostic devices is expected to fulfil this requirement.”

The Indian government’s commitment to combat diseases such as HIV and tuberculosis, and strong demand for routine diagnostic procedures such as complete blood count, coagulation analysis, and blood glucose tests are also contributing to the growth of the POC Analyzers market.

According to GlobalData’s report, ‘POC Analyzers Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030,’ medical device companies such as F. Hoffmann-La Roche Ltd, Abbott Laboratories, and Radiometer Medical ApS have designed POC devices to cater to clinical and household settings without the need for expert technicians.

Singh adds: “However, in rural areas, where there is less experience with testing technologies, the availability of trained healthcare workers is critical to accurate diagnosis and subsequent treatment. Additionally, other limitations such as POC test sensitivity compared to laboratory tests, long-term storage of tests in remote places, and adherence to testing standards and regulations should be considered by the manufacturers and healthcare facilities as adoption of POC tests in rural areas increases.”